<?xml version="1.0" encoding="UTF-8"?>
<ref id="pone.0177195.ref044">
 <label>44</label>
 <mixed-citation publication-type="journal">
  <name>
   <surname>Grebely</surname>
   <given-names>J</given-names>
  </name>, 
  <name>
   <surname>Prins</surname>
   <given-names>M</given-names>
  </name>, 
  <name>
   <surname>Hellard</surname>
   <given-names>M</given-names>
  </name>, 
  <name>
   <surname>Cox</surname>
   <given-names>AL</given-names>
  </name>, 
  <name>
   <surname>Osburn</surname>
   <given-names>WO</given-names>
  </name>, 
  <name>
   <surname>Lauer</surname>
   <given-names>G</given-names>
  </name>, 
  <etal>et al</etal>
  <article-title>Hepatitis C virus clearance, reinfection, and persistence, with insights from studies of injecting drug users: Towards a vaccine</article-title>. 
  <source>The Lancet Infectious Diseases</source>. 
  <year>2012</year>;
  <volume>12</volume>(
  <issue>5</issue>):
  <fpage>408</fpage>â€“
  <lpage>414</lpage>. 
  <pub-id pub-id-type="doi">10.1016/S1473-3099(12)70010-5</pub-id>
  <?supplied-pmid 22541630?>
  <pub-id pub-id-type="pmid">22541630</pub-id>
 </mixed-citation>
</ref>
